Estrogen also promotes cancer progression in mice bearing intraperitoneal syngeneic ID8-Defb29/Vegf-a ovarian cancer tumors and in several heterotopic murine cancer models, and this effect can be independent of estrogen receptor expression by the tumor, but require its expression on the hematopoietic and immune cells. Here, VEGFA is linked to cancer.